EGFR and squamous cell lung carcinoma: 1.A patient diagnosed with lung squamous cell carcinoma exhibiting rare concurrent epidermal growth factor receptor mutation (G719C and S768I) showed favorable response to afatinib, achieving 10 months of progression-free survival.